Sanofi, OpenAI, Formation Bio launch Muse, an AI tool for patient recruitmentnews2024-11-12T12:00:23+00:00November 12th, 2024|Endpoints News|
BenevolentAI co-founder returns with plan to save drug developernews2024-11-08T14:00:41+00:00November 8th, 2024|Endpoints News|
Nobel winner Demis Hassabis talks next steps for AI in biologynews2024-11-07T14:00:37+00:00November 7th, 2024|Endpoints News|
How Menlo Ventures thinks AI in health tech is going to be commoditizednews2024-11-07T13:16:28+00:00November 7th, 2024|Endpoints News|
Q&A: GSK’s CEO Emma Walmsley on the new Trump administration, trust, AI and Chinanews2024-11-06T18:49:02+00:00November 6th, 2024|Endpoints News|
Ferrum Health CEO: Why AI for medical care adoption has been slownews2024-11-05T12:00:58+00:00November 5th, 2024|Endpoints News|
How Define Ventures has changed its approach to AI in health technews2024-10-31T13:39:28+00:00October 31st, 2024|Endpoints News|
Nobel winner David Baker co-founds another startup, as Archon takes an AI twist on antibodiesnews2024-10-30T11:00:26+00:00October 30th, 2024|Endpoints News|
Pathos AI nabs $62M Series C as it hunts for more Phase 1 drugs with AInews2024-10-29T13:39:50+00:00October 29th, 2024|Endpoints News|
Iambic attempts to ‘break the wall’ between the lab and clinic with new AI modelnews2024-10-29T11:00:42+00:00October 29th, 2024|Endpoints News|
